Loading...

Thailand's Thonburi Hospital Group to buy six hospitals

Image

04-May-15 Thonburi Hospital Group (THG), Thailand's third-largest private hospital group, plans to invest up to THB10 bn (USD297 mn) this year acquiring six hospitals, says Dr Boon Banasin, the owner of the group. He said THG, which has a network of 22 hospitals in Thailand and abroad with 3,000 beds, aims to buy hospitals in Thailand and in China. [image: Octafinance]

Read More

China’s rising cancer rates a boon for foreign hospitals

Image

03-Jun-15 China adds 3.07 million cancer cases per year, and the disease has spawned many new businesses. This year the coal city Datong will get a private cancer hospital built by US listed Concord Medical. The company has for years supplied imaging and radiotherapy equipment to public hospitals, and is now planning to open up to 10 a year. [image: Bloomberg]

Read More

Columbia Pacific Management enters Shanghai hospital market

Image

01-Jun-15 Columbia Pacific Management – one of the largest healthcare providers in Asia, with 28 hospitals in India and Southeast Asia and three senior care facilities in China – is entering the China hospital market with a major investment in a 200-bed orthopedic hospital in Shanghai. [image: Northwest Asian Weekly]

Read More

Peking University establishes national medical data center

Image

28-May-15 A national medical data center has been established in Peking University to provide state-of-the-art analysis. The center was co-founded by the National Health & Family Planning Commission and Peking University, with the intention of building a health information system that will improve health services and administration. [image: CFP].

Read More

China hikes registration fees for drugs, medical devices

Image

27-May-15 China's drug regulator (CFDA) has raised steeply the fees required to register drugs and medical devices in the world's second-biggest pharmaceutical market, as a lack of resources and expertise hinders its ability to process the rising number of applications. The fee for registering a new locally-made drug will soar to RMB624,000 (USD101,000) compared with just RMB35,000 in 2013. [image: Pharma Logic Solutions].

Read More
Share